Rovin Capital’s FT Vest Buffered Allocation Defensive ETF BUFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$777K Sell
31,572
-2,775
-8% -$67.5K 0.21% 86
2025
Q3
$830K Sell
34,347
-121
-0.4% -$2.89K 0.23% 74
2025
Q2
$812K Sell
34,468
-343
-1% -$7.78K 0.25% 72
2025
Q1
$781K Hold
34,811
0.25% 70
2024
Q4
$781K Sell
34,811
-113
-0.3% -$2.52K 0.28% 64
2024
Q3
$772K Hold
34,924
0.29% 73
2024
Q2
$761K Hold
34,924
0.32% 63
2024
Q1
$746K Sell
34,924
-782
-2% -$16.5K 0.31% 60
2023
Q4
$744K Sell
35,706
-232
-0.6% -$4.68K 0.34% 50
2023
Q3
$708K Sell
35,938
-2,461
-6% -$49.1K 0.33% 44
2023
Q2
$764K Sell
38,399
-3,101
-7% -$59.9K 0.34% 49
2023
Q1
$789K Sell
41,500
-4,422
-10% -$82.9K 0.38% 47
2022
Q4
$847K Buy
+45,922
New +$852K 0.42% 41

Other funds holding BUFT

Rovin Capital's BUFT Position: Q4 2025 in Review

Rovin Capital reduced its FT Vest Buffered Allocation Defensive ETF (BUFT) stake by 8.1% in Q4 2025, selling an estimated $67.5K and leaving 31,572 shares worth $777K. The position accounts for 0.21% of the portfolio, ranked #86.

Rovin Capital first reported a position in BUFT in Q4 2022 and has held it in 13 quarters since. The position peaked at $847K in Q4 2022. 65 funds tracked by Wall St. Rank hold BUFT as of Q4 2025.

  • Rovin Capital held 31,572 shares of FT Vest Buffered Allocation Defensive ETF worth $777K as of Q4 2025.
  • Rovin Capital sold 2,775 FT Vest Buffered Allocation Defensive ETF shares in Q4 2025, an estimated $67.5K.
  • FT Vest Buffered Allocation Defensive ETF made up 0.21% of Rovin Capital's portfolio in Q4 2025, its #86 holding.
  • Rovin Capital first reported a position in FT Vest Buffered Allocation Defensive ETF in Q4 2022 and has held it in 13 quarters since.
  • Rovin Capital's FT Vest Buffered Allocation Defensive ETF position peaked at $847K in Q4 2022.
  • 65 funds tracked by Wall St. Rank held FT Vest Buffered Allocation Defensive ETF as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.